Clinical influence of calcium hydroxide intracanal medications on matrix metalloproteinases and tissue inhibitors of metalloproteinases in apical periodontitis

Detalhes bibliográficos
Autor(a) principal: Teixeira, Flavia F. C. [UNESP]
Data de Publicação: 2022
Outros Autores: Cardoso, Flavia G. R. [UNESP], Ferreira, Nadia S. [UNESP], Gomes, Ana P. M. [UNESP], Corazza, Bruna J. M. [UNESP], Valera, Marcia C. [UNESP], Martinho, Frederico C.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1007/s00784-021-04042-z
http://hdl.handle.net/11449/221944
Resumo: Objectives: This study investigated the influence of calcium hydroxide intracanal medications on the levels of metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in apical periodontitis (AP). Materials and methods: Twenty primarily infected root canals with AP were randomly divided into two groups: Ca(OH)2 + sterile saline solution (SSL) group and Ca(OH)2 + 2% chlorhexidine gel (CHX gel) group. We collected samples from the periradicular tissue fluid (PTF) before (s1) and after 14 days of intracanal medication (s2). MMP-1, MMP-2, MMP-9, TIMP-1, and TIMP-2 were measured by ELISA assay. Results: MMP-1, MMP-2, MMP-9, TIMP-1, and TIMP-2 were detected in all PTF samples at s1 and s2 (20/20). At s1, MMP-2 and MMP-9 were detected at higher levels than MMP-1 (p <.05). Higher levels of TIMP-1 than TIMP-2 were found in AP (p <.05). Additionally, we detected higher MMP-1, MMP-2, and MMP-9 over TIMP-1 and TIMP-2 levels in AP (p <.05). At s2, Ca(OH)2 + SSL was as effective as Ca(OH)2 + 2% CHX gel in lowering the levels of MMP-1, MMP-2, and MMP-9 after 14 days of intracanal medication, with no significant difference between them (p >.05). Both Ca(OH) 2 intracanal medications had no significant impact on the levels of TIMP-1 and TIMP-2 (both p >.05). At s2, TIMP-1 levels were higher than TIMP-2 (p <.05). Moreover, there were positive correlations between the levels of MMP-1 and TIMP-1 and MMP-1 and TIMP-2 (p <.05). Conclusions: Calcium hydroxide medications effectively lowered the levels of MMP-1, MMP-2, and MMP-9 in periapical tissues after 14 days of treatment, with no difference between them. Moreover, the calcium hydroxide intracanal medications tested here had no impact in TIMP-1 and TIMP-2 in periapical tissues. Clinical relevance: MMPs and TIMPs play an essential role in the degradation of the extracellular matrix. The imbalance MMPs and TIMPs can cause periapical tissue destruction. Therefore, the reestablishment of the balance between activated MMPs and TIMPs with root canal therapy is essential to restore tissue homeostasis.
id UNSP_33a3c9173da25c498cce470aa2524025
oai_identifier_str oai:repositorio.unesp.br:11449/221944
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Clinical influence of calcium hydroxide intracanal medications on matrix metalloproteinases and tissue inhibitors of metalloproteinases in apical periodontitisCalcium hydroxideIntracanal medicationMatrix metalloproteinaseRoot canalObjectives: This study investigated the influence of calcium hydroxide intracanal medications on the levels of metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in apical periodontitis (AP). Materials and methods: Twenty primarily infected root canals with AP were randomly divided into two groups: Ca(OH)2 + sterile saline solution (SSL) group and Ca(OH)2 + 2% chlorhexidine gel (CHX gel) group. We collected samples from the periradicular tissue fluid (PTF) before (s1) and after 14 days of intracanal medication (s2). MMP-1, MMP-2, MMP-9, TIMP-1, and TIMP-2 were measured by ELISA assay. Results: MMP-1, MMP-2, MMP-9, TIMP-1, and TIMP-2 were detected in all PTF samples at s1 and s2 (20/20). At s1, MMP-2 and MMP-9 were detected at higher levels than MMP-1 (p <.05). Higher levels of TIMP-1 than TIMP-2 were found in AP (p <.05). Additionally, we detected higher MMP-1, MMP-2, and MMP-9 over TIMP-1 and TIMP-2 levels in AP (p <.05). At s2, Ca(OH)2 + SSL was as effective as Ca(OH)2 + 2% CHX gel in lowering the levels of MMP-1, MMP-2, and MMP-9 after 14 days of intracanal medication, with no significant difference between them (p >.05). Both Ca(OH) 2 intracanal medications had no significant impact on the levels of TIMP-1 and TIMP-2 (both p >.05). At s2, TIMP-1 levels were higher than TIMP-2 (p <.05). Moreover, there were positive correlations between the levels of MMP-1 and TIMP-1 and MMP-1 and TIMP-2 (p <.05). Conclusions: Calcium hydroxide medications effectively lowered the levels of MMP-1, MMP-2, and MMP-9 in periapical tissues after 14 days of treatment, with no difference between them. Moreover, the calcium hydroxide intracanal medications tested here had no impact in TIMP-1 and TIMP-2 in periapical tissues. Clinical relevance: MMPs and TIMPs play an essential role in the degradation of the extracellular matrix. The imbalance MMPs and TIMPs can cause periapical tissue destruction. Therefore, the reestablishment of the balance between activated MMPs and TIMPs with root canal therapy is essential to restore tissue homeostasis.Department of Restorative Dentistry Endodontic Division São Paulo State University (Unesp) Institute of Science and TechnologyDivision of Endodontics Department of Advanced Oral Sciences and Therapeutics University of Maryland School of Dentistry, 650 West Baltimore StreetDepartment of Restorative Dentistry Endodontic Division São Paulo State University (Unesp) Institute of Science and TechnologyUniversidade Estadual Paulista (UNESP)University of Maryland School of DentistryTeixeira, Flavia F. C. [UNESP]Cardoso, Flavia G. R. [UNESP]Ferreira, Nadia S. [UNESP]Gomes, Ana P. M. [UNESP]Corazza, Bruna J. M. [UNESP]Valera, Marcia C. [UNESP]Martinho, Frederico C.2022-04-28T19:41:30Z2022-04-28T19:41:30Z2022-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article643-650http://dx.doi.org/10.1007/s00784-021-04042-zClinical Oral Investigations, v. 26, n. 1, p. 643-650, 2022.1436-37711432-6981http://hdl.handle.net/11449/22194410.1007/s00784-021-04042-z2-s2.0-85109997925Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengClinical Oral Investigationsinfo:eu-repo/semantics/openAccess2022-04-28T19:41:30Zoai:repositorio.unesp.br:11449/221944Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462022-04-28T19:41:30Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Clinical influence of calcium hydroxide intracanal medications on matrix metalloproteinases and tissue inhibitors of metalloproteinases in apical periodontitis
title Clinical influence of calcium hydroxide intracanal medications on matrix metalloproteinases and tissue inhibitors of metalloproteinases in apical periodontitis
spellingShingle Clinical influence of calcium hydroxide intracanal medications on matrix metalloproteinases and tissue inhibitors of metalloproteinases in apical periodontitis
Teixeira, Flavia F. C. [UNESP]
Calcium hydroxide
Intracanal medication
Matrix metalloproteinase
Root canal
title_short Clinical influence of calcium hydroxide intracanal medications on matrix metalloproteinases and tissue inhibitors of metalloproteinases in apical periodontitis
title_full Clinical influence of calcium hydroxide intracanal medications on matrix metalloproteinases and tissue inhibitors of metalloproteinases in apical periodontitis
title_fullStr Clinical influence of calcium hydroxide intracanal medications on matrix metalloproteinases and tissue inhibitors of metalloproteinases in apical periodontitis
title_full_unstemmed Clinical influence of calcium hydroxide intracanal medications on matrix metalloproteinases and tissue inhibitors of metalloproteinases in apical periodontitis
title_sort Clinical influence of calcium hydroxide intracanal medications on matrix metalloproteinases and tissue inhibitors of metalloproteinases in apical periodontitis
author Teixeira, Flavia F. C. [UNESP]
author_facet Teixeira, Flavia F. C. [UNESP]
Cardoso, Flavia G. R. [UNESP]
Ferreira, Nadia S. [UNESP]
Gomes, Ana P. M. [UNESP]
Corazza, Bruna J. M. [UNESP]
Valera, Marcia C. [UNESP]
Martinho, Frederico C.
author_role author
author2 Cardoso, Flavia G. R. [UNESP]
Ferreira, Nadia S. [UNESP]
Gomes, Ana P. M. [UNESP]
Corazza, Bruna J. M. [UNESP]
Valera, Marcia C. [UNESP]
Martinho, Frederico C.
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (UNESP)
University of Maryland School of Dentistry
dc.contributor.author.fl_str_mv Teixeira, Flavia F. C. [UNESP]
Cardoso, Flavia G. R. [UNESP]
Ferreira, Nadia S. [UNESP]
Gomes, Ana P. M. [UNESP]
Corazza, Bruna J. M. [UNESP]
Valera, Marcia C. [UNESP]
Martinho, Frederico C.
dc.subject.por.fl_str_mv Calcium hydroxide
Intracanal medication
Matrix metalloproteinase
Root canal
topic Calcium hydroxide
Intracanal medication
Matrix metalloproteinase
Root canal
description Objectives: This study investigated the influence of calcium hydroxide intracanal medications on the levels of metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in apical periodontitis (AP). Materials and methods: Twenty primarily infected root canals with AP were randomly divided into two groups: Ca(OH)2 + sterile saline solution (SSL) group and Ca(OH)2 + 2% chlorhexidine gel (CHX gel) group. We collected samples from the periradicular tissue fluid (PTF) before (s1) and after 14 days of intracanal medication (s2). MMP-1, MMP-2, MMP-9, TIMP-1, and TIMP-2 were measured by ELISA assay. Results: MMP-1, MMP-2, MMP-9, TIMP-1, and TIMP-2 were detected in all PTF samples at s1 and s2 (20/20). At s1, MMP-2 and MMP-9 were detected at higher levels than MMP-1 (p <.05). Higher levels of TIMP-1 than TIMP-2 were found in AP (p <.05). Additionally, we detected higher MMP-1, MMP-2, and MMP-9 over TIMP-1 and TIMP-2 levels in AP (p <.05). At s2, Ca(OH)2 + SSL was as effective as Ca(OH)2 + 2% CHX gel in lowering the levels of MMP-1, MMP-2, and MMP-9 after 14 days of intracanal medication, with no significant difference between them (p >.05). Both Ca(OH) 2 intracanal medications had no significant impact on the levels of TIMP-1 and TIMP-2 (both p >.05). At s2, TIMP-1 levels were higher than TIMP-2 (p <.05). Moreover, there were positive correlations between the levels of MMP-1 and TIMP-1 and MMP-1 and TIMP-2 (p <.05). Conclusions: Calcium hydroxide medications effectively lowered the levels of MMP-1, MMP-2, and MMP-9 in periapical tissues after 14 days of treatment, with no difference between them. Moreover, the calcium hydroxide intracanal medications tested here had no impact in TIMP-1 and TIMP-2 in periapical tissues. Clinical relevance: MMPs and TIMPs play an essential role in the degradation of the extracellular matrix. The imbalance MMPs and TIMPs can cause periapical tissue destruction. Therefore, the reestablishment of the balance between activated MMPs and TIMPs with root canal therapy is essential to restore tissue homeostasis.
publishDate 2022
dc.date.none.fl_str_mv 2022-04-28T19:41:30Z
2022-04-28T19:41:30Z
2022-01-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1007/s00784-021-04042-z
Clinical Oral Investigations, v. 26, n. 1, p. 643-650, 2022.
1436-3771
1432-6981
http://hdl.handle.net/11449/221944
10.1007/s00784-021-04042-z
2-s2.0-85109997925
url http://dx.doi.org/10.1007/s00784-021-04042-z
http://hdl.handle.net/11449/221944
identifier_str_mv Clinical Oral Investigations, v. 26, n. 1, p. 643-650, 2022.
1436-3771
1432-6981
10.1007/s00784-021-04042-z
2-s2.0-85109997925
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Clinical Oral Investigations
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 643-650
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1797790147553525760